Procurement inquiry: How are the lead times for imported reverse transcriptase kits recently? Are there any reliable domestic alternatives?

Recently, import cold-chain lead times have indeed been unstable, and delays of more than three weeks are not uncommon. It is advisable not to rely solely on the agent's page status; instead, ask the regional sales or technical support directly whether there is stock in a local sub-warehouse, small-pack stock, or an alternative catalog number. Sometimes the lead times for different pack sizes of the same brand vary greatly: the 200-test large pack may be out of stock, while the 100-test small pack may be available. You can also ask whether stock can be transferred from another region. If you confirm that you must wait, have the agent provide a written arrival time, and at the same time initiate a domestic alternative; do not just wait idly.

Total RNA from cell lines is relatively consistent, and many domestic reverse transcriptases are already up to the task of routine reverse transcription. When selecting, don't just rely on brand promotion—ask the supplier to provide COAs for three batches and check the enzyme activity units, RNase residue, and functional assay CV; it's best to choose manufacturers with an OEM background or an industrial customer base. For 20–30 samples, you can apply for a trial sample and run a same-plate comparison using the same batch of cellular RNA and imported reagents, looking at Ct values and melting curves. There are many options in the 300–400 yuan/100-reaction range, but prioritize those with complete batch documentation.

Whether you choose domestic reagents or imported ones in stock, it is recommended to first perform a gradient test using cell line RNA: for example, reverse transcribe 500 ng, 1 μg, and 2 μg separately, then run qPCR to assess amplification efficiency and linearity. Focus on whether Ct values remain stable at low input amounts and whether inhibition occurs at high input amounts. The buffer system and enzyme activity units of domestic reagents may differ from imported ones, so do not simply substitute by volume; it is best to perform a gradient confirmation. Comparisons are only objective when performed on the same plate with the same primers.

20-30 samples is not a small number. It is recommended to prioritize premixed or 2× RT master mixes containing reverse transcriptase, buffer, dNTPs, and primers to reduce pipetting steps and human error. During procurement, confirm whether RNase inhibitors are included, whether stable storage is possible, and the number of freeze-thaw cycles tolerated. If sample throughput is high, consider lyophilized or aliquoted specifications to avoid repeated freeze-thaw affecting intra-batch consistency. When selecting domestic alternatives, clarify whether they are compatible with the cDNA input amount for subsequent qPCR to avoid buffer inhibition of Taq.

If the project timeline is tight, you can first buy a small domestic pack instead of directly replacing all samples. Take the same cell line RNA, perform reverse transcription simultaneously with the old and new reagents, and aliquot the cDNA into small tubes. Use one portion for qPCR immediately, and store another portion at -20 or -80 for one week before retesting to observe intra-batch and storage stability. If the small-scale test results show acceptable differences from the imported product, then expand to 20-30 samples. During procurement, require the supplier to provide technical support and be able to respond to troubleshooting when amplification abnormalities occur, rather than just selling reagents.